Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin

T. H. Liu, Y. J. Tang, Y. Huang, Lan Wang, X. L. Guo, J. Q. Mi, L. G. Liu, H. Zhu, Y. Zhang, L. Chen, X. Liu, L. H. Zhang, Q. J. Ye, B. S. Li, J. Y. Tang, A. Ford, T. Enver, F. Liu, G. Q. Chen, D. L. Hong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The origin of cancers is associated with etiology as well as therapeutics. Several studies reveal that malignancies in children can originate in utero. However, a diagnostic approach to distinguish between cancers initiated pre- or postnatally is absent. Here we identified a transcriptional factor FEV (fifth Ewing variant) that was expressed in fetal hematopoietic cells and became silent after birth. We characterized that FEV was essential for the self-renewal of hematopoietic stem cells (HSCs). We next found that FEV was expressed in most infant leukemia samples, but seldom in adult samples, in accord with the known prenatal origins of the former. We further determined the majority of pediatric acute lymphoid leukemia (ALL) and acute myeloid leukemia (AML) were FEV positive. Moreover, FEV knockdown markedly impaired the leukemia-propagating ability of leukemic stem cells. We therefore identified FEV is unique to fetal HSCs and stably expressed in leukemic cells of prenatal origin. It may also provide a tractable therapeutic target.Leukemia advance online publication, 9 December 2016; doi:10.1038/leu.2016.313.

Original languageEnglish (US)
JournalLeukemia
DOIs
StateAccepted/In press - Dec 9 2016

Fingerprint

Hematopoiesis
Leukemia
Hematopoietic Stem Cells
Fetal Stem Cells
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Publications
Stem Cells
Parturition
Pediatrics
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Liu, T. H., Tang, Y. J., Huang, Y., Wang, L., Guo, X. L., Mi, J. Q., ... Hong, D. L. (Accepted/In press). Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin. Leukemia. https://doi.org/10.1038/leu.2016.313

Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin. / Liu, T. H.; Tang, Y. J.; Huang, Y.; Wang, Lan; Guo, X. L.; Mi, J. Q.; Liu, L. G.; Zhu, H.; Zhang, Y.; Chen, L.; Liu, X.; Zhang, L. H.; Ye, Q. J.; Li, B. S.; Tang, J. Y.; Ford, A.; Enver, T.; Liu, F.; Chen, G. Q.; Hong, D. L.

In: Leukemia, 09.12.2016.

Research output: Contribution to journalArticle

Liu, TH, Tang, YJ, Huang, Y, Wang, L, Guo, XL, Mi, JQ, Liu, LG, Zhu, H, Zhang, Y, Chen, L, Liu, X, Zhang, LH, Ye, QJ, Li, BS, Tang, JY, Ford, A, Enver, T, Liu, F, Chen, GQ & Hong, DL 2016, 'Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin', Leukemia. https://doi.org/10.1038/leu.2016.313
Liu, T. H. ; Tang, Y. J. ; Huang, Y. ; Wang, Lan ; Guo, X. L. ; Mi, J. Q. ; Liu, L. G. ; Zhu, H. ; Zhang, Y. ; Chen, L. ; Liu, X. ; Zhang, L. H. ; Ye, Q. J. ; Li, B. S. ; Tang, J. Y. ; Ford, A. ; Enver, T. ; Liu, F. ; Chen, G. Q. ; Hong, D. L. / Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin. In: Leukemia. 2016.
@article{5225c45fd4714516848a9f3f77cebbe4,
title = "Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin",
abstract = "The origin of cancers is associated with etiology as well as therapeutics. Several studies reveal that malignancies in children can originate in utero. However, a diagnostic approach to distinguish between cancers initiated pre- or postnatally is absent. Here we identified a transcriptional factor FEV (fifth Ewing variant) that was expressed in fetal hematopoietic cells and became silent after birth. We characterized that FEV was essential for the self-renewal of hematopoietic stem cells (HSCs). We next found that FEV was expressed in most infant leukemia samples, but seldom in adult samples, in accord with the known prenatal origins of the former. We further determined the majority of pediatric acute lymphoid leukemia (ALL) and acute myeloid leukemia (AML) were FEV positive. Moreover, FEV knockdown markedly impaired the leukemia-propagating ability of leukemic stem cells. We therefore identified FEV is unique to fetal HSCs and stably expressed in leukemic cells of prenatal origin. It may also provide a tractable therapeutic target.Leukemia advance online publication, 9 December 2016; doi:10.1038/leu.2016.313.",
author = "Liu, {T. H.} and Tang, {Y. J.} and Y. Huang and Lan Wang and Guo, {X. L.} and Mi, {J. Q.} and Liu, {L. G.} and H. Zhu and Y. Zhang and L. Chen and X. Liu and Zhang, {L. H.} and Ye, {Q. J.} and Li, {B. S.} and Tang, {J. Y.} and A. Ford and T. Enver and F. Liu and Chen, {G. Q.} and Hong, {D. L.}",
year = "2016",
month = "12",
day = "9",
doi = "10.1038/leu.2016.313",
language = "English (US)",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin

AU - Liu, T. H.

AU - Tang, Y. J.

AU - Huang, Y.

AU - Wang, Lan

AU - Guo, X. L.

AU - Mi, J. Q.

AU - Liu, L. G.

AU - Zhu, H.

AU - Zhang, Y.

AU - Chen, L.

AU - Liu, X.

AU - Zhang, L. H.

AU - Ye, Q. J.

AU - Li, B. S.

AU - Tang, J. Y.

AU - Ford, A.

AU - Enver, T.

AU - Liu, F.

AU - Chen, G. Q.

AU - Hong, D. L.

PY - 2016/12/9

Y1 - 2016/12/9

N2 - The origin of cancers is associated with etiology as well as therapeutics. Several studies reveal that malignancies in children can originate in utero. However, a diagnostic approach to distinguish between cancers initiated pre- or postnatally is absent. Here we identified a transcriptional factor FEV (fifth Ewing variant) that was expressed in fetal hematopoietic cells and became silent after birth. We characterized that FEV was essential for the self-renewal of hematopoietic stem cells (HSCs). We next found that FEV was expressed in most infant leukemia samples, but seldom in adult samples, in accord with the known prenatal origins of the former. We further determined the majority of pediatric acute lymphoid leukemia (ALL) and acute myeloid leukemia (AML) were FEV positive. Moreover, FEV knockdown markedly impaired the leukemia-propagating ability of leukemic stem cells. We therefore identified FEV is unique to fetal HSCs and stably expressed in leukemic cells of prenatal origin. It may also provide a tractable therapeutic target.Leukemia advance online publication, 9 December 2016; doi:10.1038/leu.2016.313.

AB - The origin of cancers is associated with etiology as well as therapeutics. Several studies reveal that malignancies in children can originate in utero. However, a diagnostic approach to distinguish between cancers initiated pre- or postnatally is absent. Here we identified a transcriptional factor FEV (fifth Ewing variant) that was expressed in fetal hematopoietic cells and became silent after birth. We characterized that FEV was essential for the self-renewal of hematopoietic stem cells (HSCs). We next found that FEV was expressed in most infant leukemia samples, but seldom in adult samples, in accord with the known prenatal origins of the former. We further determined the majority of pediatric acute lymphoid leukemia (ALL) and acute myeloid leukemia (AML) were FEV positive. Moreover, FEV knockdown markedly impaired the leukemia-propagating ability of leukemic stem cells. We therefore identified FEV is unique to fetal HSCs and stably expressed in leukemic cells of prenatal origin. It may also provide a tractable therapeutic target.Leukemia advance online publication, 9 December 2016; doi:10.1038/leu.2016.313.

UR - http://www.scopus.com/inward/record.url?scp=85001759314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85001759314&partnerID=8YFLogxK

U2 - 10.1038/leu.2016.313

DO - 10.1038/leu.2016.313

M3 - Article

C2 - 27807368

AN - SCOPUS:85001759314

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -